Transaction · 0001193125-26-385541

Rothfuss Cristin

Rothfuss Cristin, EVP, GC, reported a transaction classified as withholding at Sarepta Therapeutics, Inc. involving 22025.000000 shares for an estimated $489395.50. Reported holdings after the transaction were 115519.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FEVP, GC
SRPTSarepta Therapeutics, Inc.
Filing timeSep 09
Trade dateSep 04, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$22.99
Pre-filing
1mo ago1w ago -9.3%1d ago +0.0%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

SRPT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
SRPT since 2026-09-09Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001193125-26-385541
Common Stock
Transaction date
Sep 04, 2026
Filed Sep 09, 2026, 12:02 AM · 5d delay
Shares
22.0k sh
$2.22k per share
Estimated value
-$48.9M
Computed from shares × price
Holdings after
115k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025.

Original filing · 0001193125-26-385541
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

SRPT